全部新闻

讨论、会议及分享

网络研讨会和播客

Presentation of annual results for 2023 and ambitions for 2024

22 4 月 2024

Intrasense presents its 2023 annual results.Discover in this webinar the progress of Intrasense's medical imaging solutions, its 2024 objectives and ambitions.

观看视频

Presentation of the half-yearly financial results 2022

21 10 月 2022

To coincide with the publication of its half-year results for 2022, Intrasense will provide an update on its latest developments.

观看视频

Presentation of 2021 annual results and 2022 ambitions

14 3 月 2022

On the occasion of the publication of its 2021 annual results, Intrasense will provide an update on its latest developments.

观看视频

Demo of the new COVID-19 dedicated protocol

2 4 月 2020

This protocol offers numerous clinical advantages, particularly in terms of screening, pathological stage analysis and pathological progression.

观看视频

所有的网络研讨会

新闻稿

Intrasense announces its 2024

25 7 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow® (the "Company"), today announced its half-year revenue for 2024 IFRS consolidated at Group level.

发现更多

Intrasense presents its AI innovations at the SIRM congress in Italy

10 6 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^® and Liflow^®, announces its participation in SIRM, the congress organized by the Italian Society of Medical and Interventional Radiology, to be held from June 20 to 23 in Milan (Italy).

发现更多

Intrasense announces CE certification of Liflow® to the new European regulation (MDR)

29 4 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, is proud to announce that the company has obtained CE certification under MDR (European Union Medical Device Regulation 2017/745), for the first version of its Liflow® solution.

发现更多

Intrasense announces the appointment of Jérôme Thiebaud as Chief Business Officer

24 4 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^® and Liflow^®, announces the appointment of Jérôme Thiebaud as the Group's Chief Business Officer.

发现更多

Liflow®: an innovative AI-enhanced solution to optimize oncology follow-up

16 4 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^® and Liflow^®, announces the regulatory submission of its Liflow^® 1.0 solution (registered trademark of the Myra project), an oncology platform dedicated to the analysis of diagnostic imaging and cancer follow-up.

发现更多

1 2 3 … 20 下一页 »

全部的新闻稿